Spinout from The University of Manchester developing crop engineering technology for precise gene editing in plant organelles (chloroplasts and mitochondria) via its proprietary MOSS platform to enable improved crop traits, resilience and sustainable agriculture.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| £3 M | Mar, 2026 | seed |
Industries
Frequently Asked Questions
Where is Cytotrait located?
Cytotrait is located in Manchester, United Kingdom.
What industries does Cytotrait operate in?
Cytotrait operates in the following industries: agricultural biotechnology, gene editing, agritech.
How much total funding has Cytotrait raised?
Cytotrait has raised a total of $3,000,000.
Who are the investors in Cytotrait?
The investors in Cytotrait are: Northern Gritstone, Future Planet Capital, Parkwalk Advisors / Northern Universities Ventures Fund, UK Innovation & Science Seed Fund (UKI2S), ARIA (Advanced Research and Invention Agency).
What is the main mission of Cytotrait in the agricultural sector?
Cytotrait focuses on developing novel traits for food and agriculture by reprogramming chloroplast and mitochondrial genomes to address global challenges like food security and sustainability.
What is the proprietary MOSS technology developed by Cytotrait?
The Mutant Organelle Selection System, or MOSS, is a platform that introduces genes and gene edits into plant organelles to rapidly achieve homoplasmy, ensuring every organelle in a cell contains the desired genetic change.
Which specific crops is Cytotrait targeting with its current research programs?
The company is currently applying its technology to improve major crops including wheat, maize, potato, and canola in markets across Europe and North America.
How does Cytotrait assist in the development of climate-resilient farming?
By enhancing crop yields and resilience through precise organelle modification, the organization supports practices that improve carbon sequestration and reduce the environmental impact of farming.
What makes the approach used by Cytotrait different from traditional gene editing?
Unlike conventional nuclear genome engineering, this method targets plant organelles to unlock high-value trait expression with reduced phytotoxicity and streamlined regulatory paths.